PHILIP MORRIS INTERNATIONAL (PM)

Sunday

11:05 AM

Thesis: The strong performance of IQOS and favorable regulatory developments are shifting investor sentiment positively towards Philip Morris.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$40.6B	$43.5B	$46.2B
Rev. Growth	+7.3%	+6.9%	+6.3%
EPS	$7.27	$8.37	$9.13
EPS Growth	+60.5%	+15.1%	+9.1%
P/E (fwd)	24.9×	21.6×	19.8×

★ Analysts see FY2026 revenue reaching $43.5B — +6.9% growth in a single year.

What’s Driving the Stock

1IQOS sales in Japan have increased by 25% YoY, indicating strong consumer acceptance and potential for market expansion.
2Regulatory approval for reduced-risk products in the EU could open up a $10B market opportunity.
3Recent price increases on traditional cigarette products have led to a 5% increase in revenue per unit sold.
4Emerging markets are showing a 15% increase in tobacco consumption, providing new growth avenues.
5Shift towards reduced-risk products
6Increased regulatory focus on health and wellness
7Changes in regulatory frameworks affecting tobacco sales in key markets
8Growth in reduced-risk product adoption, particularly IQOS in Europe and Asia

FY2025 Snapshot

Revenue: $40.6B
Rev. Growth: +7.3%
Gross Margin: 67.1%
Op. Margin: 36.7%
Net Margin: 27.9%
Net Income: $11.3B
NI Growth: +61.3%
EPS: $7.27
1Y Return: +5.1%

My Notes

"Management has highlighted a 'transformative phase' as the company pivots towards smoke-free products."
Moat: Philip Morris has a strong brand portfolio and significant market share, providing a durable competitive advantage.
dividend - the company has a strong history of returning capital to shareholders through dividends, appealing to income-focused investors.
Low - the company's debt levels are manageable, and interest rates primarily affect consumer spending rather than direct financing costs.
Watch on earnings: Market penetration rates of IQOS, Tobacco leaf prices, Regulatory changes in key markets.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $43.5B to $46.2B as iqos sales in japan have increased by 25% yoy, indicating strong consumer acceptance and potential for market expansion.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.